Peripheral Artery Disease Market Size, Share, Trends Report 2024-2032

IMARC Group’s report titled “Peripheral Artery Disease Market Report by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Specialty Clinics, and Others), and Region 2024–2032”. The global peripheral artery disease market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024–2032.

Grab a sample PDF of this report: https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample

Factors Affecting the Growth of the Peripheral Artery Disease Industry:

• Increasing Prevalence of Diabetes and Obesity:

The global rise in diabetes and obesity is driving the market growth. Diabetes is characterized by extremely high blood sugar levels, which over time damages blood vessels and leads to peripheral arterial disease (PAD). Similarly, obesity promotes arteriosclerosis and aggravates the risk of developing cardiovascular diseases, including PAD. As these diseases become more prevalent due to changing lifestyles, dietary habits, and an aging population, the demand for PAD treatment is increasing. This trend highlights the need for advanced therapeutic approaches, including medications, lifestyle interventions, and surgery, to manage PAD.

• Technological Advancements in Treatment and Diagnosis:

Development of cutting-edge technologies for the treatment and diagnosis of PAD is a pivotal factor driving the growth of the market. Innovations in minimally invasive (MI) surgical techniques such as angioplasty and stenting have improved outcomes for PAD patients by reducing recovery times and complications. Furthermore, advancements in diagnostic imaging technologies such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) scans have improved the accuracy and efficiency of PAD diagnosis, facilitating early detection and treatment. These technological advancements are not only improving patient care but also increasing the demand for advanced PAD management solutions.

• Growing Awareness and Screening Programs:

Increasing awareness and screening efforts regarding PAD are supporting the growth of the market. Government and non-governmental organizations are increasingly focusing on educational campaigns to raise awareness about the risk factors, symptoms, and key aspects of early detection of PAD. Screening programs targeting high-risk populations such as elderly people, diabetics, and those with a history of smoking are becoming more prevalent. These efforts enable early diagnosis and treatment, thus increasing the demand for PAD-related healthcare services and products.

Leading Companies Operating in the Global Peripheral Artery Disease Industry:

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Koninklijke Philips N.V.
• Medtronic plc
• iTerumo Corporation

Peripheral Artery Disease Market Report Segmentation:

By Type:

• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories

Peripheral stents represent the largest segment as they are adopted to widen narrowed or blocked arteries, thereby enhancing blood flow to the affected regions.

By End User:

• Hospitals
• Specialty Clinics
• Others

On the basis of the end user, the market has been divided into hospitals, specialty clinics, and others.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the peripheral artery disease market is attributed to the growing occurrence of various chronic diseases among the masses.

Global Peripheral Artery Disease Market Trends:

Evolving insurance coverage and reimbursement policies are driving the market growth. Additionally, changes in healthcare policies including expanded insurance coverage for the diagnosis and treatment of PAD are removing financial barriers for patients. These policy changes have made PAD treatment more accessible and affordable, leading to increased utilization of healthcare services. Reimbursement policies encouraging the use of advanced PAD treatments such as drug-eluting stents and newer pharmacological therapies are encouraging healthcare providers to adopt these new technologies. Additionally, the increasing incidence of PAD among the elderly population is also driving the market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145